Endometrial hyperplasia as a risk factor of endometrial cancer
2022 · Archives of Gynecology and Obstetrics · 141 citations
https://doi.org/10.1007/s00404-021-06380-5
S
Sabine Heublein
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
201
Papers
1.9K
Citations
26
h-index
50
i10-index
Sabine Heublein is an academic researcher from Heidelberg University. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Breast Cancer Treatment Studies & Estrogen and related hormone effects. The author has an h-index of 26, co-authored 171 publications.
ORCID: 0000-0002-5326-0186Papers by this author
worksGlycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients
2012 · BMC Research Notes · 40 citations
https://doi.org/10.1186/1756-0500-5-551
Validated biomarker assays confirm that <scp>ARID1A</scp> loss is confounded with <scp>MMR</scp> deficiency, <scp> CD8 <sup>+</sup> TIL </scp> infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas
2021 · The Journal of Pathology · 40 citations
https://doi.org/10.1002/path.5849
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
2022 · Cancer · 39 citations
https://doi.org/10.1002/cncr.34582
Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
2017 · Journal of Experimental & Clinical Cancer Research · 32 citations
https://doi.org/10.1186/s13046-017-0517-1
M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
2020 · Cells · 28 citations
https://doi.org/10.3390/cells9051224
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat